What is the recommended dosing regimen for a patient with type 1 diabetes on 70/30 (neutral protamine Hagedorn (NPH)/regular) insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dosing Regimen for Type 1 Diabetes on 70/30 Insulin

For patients with type 1 diabetes, a basal-bolus insulin regimen is strongly recommended over premixed 70/30 (NPH/regular) insulin due to significantly increased risk of hypoglycemia with premixed insulin formulations. 1

Why Basal-Bolus is Preferred for Type 1 Diabetes

  • Guidelines from the American Diabetes Association consistently recommend against premixed insulin regimens for patients with type 1 diabetes 1
  • A randomized inpatient study comparing 70/30 NPH/regular insulin versus basal-bolus therapy showed comparable glycemic control but significantly increased hypoglycemia in the premixed insulin group 1
  • For type 1 diabetes, dosing insulin based solely on premeal glucose levels (as with premixed insulin) does not account for basal insulin requirements or caloric intake, increasing both hypoglycemia and hyperglycemia risks 1

If 70/30 Insulin Must Be Used (Despite Recommendations Against It)

If a patient with type 1 diabetes must use 70/30 insulin due to access, cost, or other constraints:

Dosing Schedule

  • Twice-daily administration is typically required
  • Morning dose: Before breakfast
  • Evening dose: Before dinner
  • Total daily dose: Usually 0.5-0.7 units/kg/day, divided between morning and evening doses 2

Dose Distribution

  • Morning dose: Usually higher (approximately 60-70% of total daily dose)
  • Evening dose: Usually lower (approximately 30-40% of total daily dose) 1
  • Example: For a 70kg patient requiring 0.6 units/kg/day (42 units total)
    • Morning dose: 25-30 units
    • Evening dose: 12-17 units

Timing of Administration

  • Regular insulin component requires administration 30 minutes before meals 3
  • This timing is critical to match insulin action with food absorption

Blood Glucose Monitoring Requirements

More intensive monitoring is required with premixed insulin:

  • Pre-breakfast and pre-dinner (essential)
  • 2 hours post-breakfast and post-dinner (to assess postprandial control)
  • Bedtime and occasional 3 AM readings (to detect nocturnal hypoglycemia)
  • During illness or significant changes in routine

Adjustments and Considerations

  • Dose adjustments should be made cautiously, typically 10-15% at a time
  • Morning dose affects:
    • Daytime glucose levels
    • Pre-dinner glucose
  • Evening dose affects:
    • Overnight glucose levels
    • Pre-breakfast glucose

Important Cautions and Limitations

  • Fixed ratio of 70/30 severely limits flexibility in dosing
  • Cannot independently adjust basal and bolus components
  • High risk of hypoglycemia, especially nocturnal
  • Requires consistent meal timing, content, and carbohydrate amounts
  • Exercise and activity must be carefully planned
  • Not suitable for patients with variable schedules or eating patterns

Transition to Preferred Regimen

Ideally, patients with type 1 diabetes should transition to a basal-bolus regimen consisting of:

  • Once or twice daily long-acting insulin (glargine, detemir, degludec)
  • Rapid-acting insulin before meals
  • This regimen allows for greater flexibility, better glycemic control, and reduced hypoglycemia risk 4

Remember that premixed insulin regimens are not routinely recommended for patients with type 1 diabetes due to the significantly increased risk of hypoglycemia and limited flexibility in dosing. A basal-bolus insulin regimen is strongly preferred for this population.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Research

Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.